Is there a role for nitric oxide in hyperlactataemia syndromes and mitochondrial dysfunction associated with HIV therapy?
Torre
Donato
D
Department of Infectious Diseases, General Hospital and Macchi Foundation, Varese, Italy. donatotorre@libero.it
Speranza
Filippo
F
D000140:Acidosis, Lactic / Q000209:etiology / Q000517:prevention & control*; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000494:pharmacology; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism; D017240:Mitochondrial Myopathies / Q000209:etiology / Q000517:prevention & control*; D009569:Nitric Oxide / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000494:pharmacology; D013577:Syndrome
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D009569:Nitric Oxide